Imunon
IMNN
18 hedge funds and large institutions have $287K invested in Imunon in 2023 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 3 reducing their positions, and 1 closing their positions.
300% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 1
67% more repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 3
20% more funds holding
Funds holding: 15 → 18 (+3)
0.01% more ownership
Funds ownership: 0.34% → 0.34% (+0.01%)
29% less capital invested
Capital invested by funds: $403K → $287K (-$116K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
HF
HRT Financial
New York
|
+$26.7K |
| 2 |
VF
Virtu Financial
New York
|
+$24.2K |
| 3 |
TSS
Two Sigma Securities
New York
|
+$12.9K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$11.3K |
| 5 |
Renaissance Technologies
New York
|
+$6.73K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$66.2K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$14.3K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$73 |
| 4 |
JP Morgan Chase
New York
|
-$11 |
IMNN Hedge Fund Activity: Q4 2023 in Review
18 of the 6,859 institutional investors tracked by Wall St. Rank reported a position in Imunon (IMNN) for Q4 2023, worth a combined $287K — down 29% from $403K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new IMNN positions and 1 closed out — a net gain of 3 holders — while 5 added to existing stakes and 3 trimmed.
The largest buyer was HRT Financial, opening a new position worth an estimated $26.7K. The largest seller was Vanguard Group, cutting an estimated $66.2K.
- 18 institutional investors held Imunon (IMNN) as of Q4 2023, up from 15 in Q3 2023.
- Funds reported $287K of Imunon stock for Q4 2023, down 29% quarter-over-quarter.
- 4 funds opened new Imunon positions in Q4 2023 and 1 closed out, a net change of +3 holders.
- The largest Imunon buyer in Q4 2023 was HRT Financial, an estimated $26.7K added.
- The largest Imunon seller in Q4 2023 was Vanguard Group, an estimated $66.2K sold.
Based on aggregated 13F filings for Q4 2023.